The Rise of Unregulated 'Peptide Companies' Amidst GLP-1 Drug Shortage

  • 📰 ScienceAlert
  • ⏱ Reading Time:
  • 25 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 68%

Health & Medicine أخبار

GLP-1,Ozempic,Wegovy

As demand for brand-name injectable weight loss drugs like Ozempic and Wegovy skyrockets, the market is flooded with unregulated peptide companies selling knockoff versions of these medications. This article explores the dangers associated with these unapproved products and examines the efforts being made to address the shortage of legitimate GLP-1 drugs.

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame asBoth drugs mimic the naturally occurring hormone GLP-1 to help regulate blood sugar and reduce cravings. They can be taken only with a prescription.

From November 2023 to March 2024, my team carried out a study to assess which of these peptide companies are selling semaglutide or tirzepatide products. We scoured the internet looking for these peptide companies and collected information about what they were selling and their sales practices..

Unlike compounding pharmacies, these peptide sellers do not provide the supplies you need to dissolve and inject the drug, provide no instructions, and will usually not answer questions.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 63. in SA
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين